相关实验视频
Updated: Feb 7, 2026

13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
24.7K
乙型肝炎病毒中的淫荡金属部位X蛋白与Fe-S集群结合
bioRxiv : the preprint server for biology
|February 6, 2026
概括
乙型肝炎病毒 (HBV) 调控蛋白HBx使用特定的半氨酸残留物来结合铁硫 (Fe-S) 集群,这对病毒复制至关重要. 这一发现揭示了针对HBV的抗病毒疗法的潜在新目标.
科学领域:
- 生物化学 生物化学
- 病毒学 病毒学
- 分子生物学分子生物学
背景情况:
- 乙型肝炎病毒 (HBV) 调节蛋白HBx对于病毒复制和疾病至关重要.
- 它的辅因子特异性和金属结合环境尚不清楚.
- HBx的内在疾病和突变耐受性使其表征变得复杂.
研究的目的:
- 为了识别HBx蛋白内特定的金属协调配体.
- 阐明金属结合在HBx功能和HBV病变发生中的作用.
- 探索与HBx金属结合相关的潜在治疗漏洞.
主要方法:
- 整合化学蛋白质组学和HYSCORE光谱学,绘制金属结合部位的地图.
- 突变分析以证实已识别的氨酸残留物的作用.
- 评估HBx与宿主Fe-S集群机械的相互作用.
主要成果:
- 氨酸残留物C61,C69,C143和C148被确定为Fe-S集群的初级配体.
- 氨酸C137作为Fe-S集群的条件连接体.
- 这些残留物还与协调,并与HBx交换活化和疾病相关变异有关.
- HBx 与宿主细胞质Fe-S机制相互作用,对Fe-S向剂敏感.
结论:
- HBx作为Fe-S集群相关蛋白质起作用.
- 已确定的金属结合部位代表了抑制HBV复制的潜在可用药物标.
- 了解HBx金属协调提供了对HBV病变的新见解.
相关概念视频
Hepatic Drug Clearance: Effect of Protein Binding
563
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
563
What are Viruses?
128.3K
Overview
128.3K
Conserved Binding Sites
5.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.2K
Factors Affecting Protein-Drug Binding: Protein-Related Factors
574
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
574
Metal-Ligand Bonds
24.4K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
24.4K
The Equilibrium Binding Constant and Binding Strength
15.1K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.1K

